References
- Magrath I T. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133–270
- Burkitt D P. The discovery of Burkitt's lymphoma. Cancer 1983; 51: 1777–1786
- Harris N, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Arlie House, Virginia, November 1997. J Clini Oncol 1999; 17: 3835–3849
- Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubiana M. Report of a committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Eng J Med 1993; 329: 987–994
- Bernstein J, Coleman C, Strickler J, Dorfman R, Rosenberg S. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 1986; 4: 847–858
- Thomas D, Cortes J, O'Brien S, Pierce S, Faderl S, Albitar M, et al. HyperCVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol 1999; 17: 2461–2470
- Thomas D, Faderl S, Kantarjian H, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles F J, Verstovsek S, Wierda W G, Pierce S A, Shan J, Brandt M, Hagemeister F B, Keating M J, Cabanillas F, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 2006; 106: 1569–1580
- Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage – a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 1995; 13: 359–372
- Blum K A, Lozanski G, Byrd J C. Adult Burkitt leukemia and lymphoma. Blood 2004; 104: 3009–3020
- Ferry J A. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 2006; 11: 375–383
- Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regime. J Clin Oncol 1996; 14: 925–934
- Mead G M, Sydes M R, Walewski J, Grigg A, Hatton C S, Norbert P, et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 2002; 13: 1264–1274
- Chia KS, Seow A, Lee HP, Shanmugaratnam K. Cancer incidence in Singapore 1993 – 1997, Singapore Cancer Registry Report No. 5.
- Labrecque L G, Xue Shao-an, Griffin B E, Kazembe P, Phillips J, Lampert I, Wedderburn N, et al. Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. Int J Cancer 1999; 81: 6–11